New data shows HIV and AIDS infections are increasing in Chicago’s Latino community, even as cases decline among other groups ...

Advocates warn reductions to drug access, eligibility and provider contracts could disrupt care for thousands across South ...

UNAIDS commends the Global Fund to Fight AIDS, TB and Malaria and the United States for their commitment to further increase access to long-acting HIV prevention medication. In a recent statement they ...

With the foreign funding greatly reduced, the onus is on the Government of Uganda to find other sources of revenue locally to ...

A resurfaced clip of Heated Rivalry creator Jacob Tierney from four years ago is getting praise for his frank discussion ...

The AIDS Healthcare Foundation is criticizing Gilead Sciences over the cost of HIV medications. Advocates warn that high drug ...

Researchers combined this first antibody treatment with another drug designed to force HIV out of hidden reservoirs in the ...

The recent news about a temporary funding patch for the state’s AIDS Drug Assistance Program (ADAP) is a welcome reprieve for ...

Uganda is taking a giant leap towards an HIV-free generation. This Friday, the country will launch Lenacapavir, a long-acting ...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Shionogi as a shareholder, today released "Still Here," a social media video campaign designed to spark crucial ...

Gilead's lenacapavir could transform the fight against HIV — but only if millions more patients can get it.

The US is reportedly leveraging health aid to gain access to Zambia's critical minerals. Millions depend on US funding for ...